Emerging evidence demonstrates that CAFs not only respond to oncogenic signals but also actively drive tumor progression through paracrine factor secretion (e.g., TGF-β, IL-6) and extracellular matrix remodeling, and act as critical collaborators in hepatocarcinogenesis (4, 7, 8). This evidence concerns the gene IL6 and neoplasm.